These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6130476)

  • 1. Release of somatostatin-28(1-12) from rat hypothalamus in vitro.
    Bakhit C; Benoit R; Bloom FE
    Nature; 1983 Feb; 301(5900):524-6. PubMed ID: 6130476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for selective release of somatostatin-14 and somatostatin-28(1-12) from rat hypothalamus.
    Bakhit C; Koda L; Benoit R; Morrison JH; Bloom FE
    J Neurosci; 1984 Feb; 4(2):411-9. PubMed ID: 6142098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunocytochemical localization of somatostatin-28 in the rat hypothalamus.
    Guy J; Benoit R; Pelletier G
    Brain Res; 1985 Mar; 330(2):283-9. PubMed ID: 2859089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple forms of somatostatin-like immunoreactivity in the hypothalamus and amygdala of the rat: selective localization of somatostatin-28 in the median eminence.
    Pierotti AR; Harmar AJ
    J Endocrinol; 1985 Jun; 105(3):383-9. PubMed ID: 2860197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical distribution of pro-somatostatin-related peptides in cerebral cortex.
    Morrison JH; Benoit R; Magistretti PJ; Bloom FE
    Brain Res; 1983 Mar; 262(2):344-51. PubMed ID: 6132664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of somatostatin-28-(1-12) in hypothalamus and pancreas.
    Benoit R; Böhlen P; Ling N; Briskin A; Esch F; Brazeau P; Ying SY; Guillemin R
    Proc Natl Acad Sci U S A; 1982 Feb; 79(3):917-21. PubMed ID: 6121326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin-28 [1-12]-like peptides.
    Benoit R; Bohlen P; Ling N; Esch F; Baird A; Ying SY; Wehrenberg WB; Guillemin R; Morrison JH; Bakhit C
    Adv Exp Med Biol; 1985; 188():89-107. PubMed ID: 2863951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different patterns of molecular forms of somatostatin are released by the rat median eminence and hypothalamus.
    Pierotti AR; Harmar AJ; Tannahill LA; Arbuthnott GW
    Neurosci Lett; 1985 Jun; 57(3):215-20. PubMed ID: 2863791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of somatostatin receptors in guinea-pig isolated ileum, vas deferens and right atrium.
    Feniuk W; Dimech J; Humphrey PP
    Br J Pharmacol; 1993 Nov; 110(3):1156-64. PubMed ID: 7905341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in vivo metabolism of somatostatin 28: possible relationship between diminished metabolism and enhanced biological action.
    Polonsky K; Jaspan J; Berelowitz M; Pugh W; Moossa A; Ling N
    Endocrinology; 1982 Nov; 111(5):1698-703. PubMed ID: 6127205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cysteamine on pro-somatostatin related peptides.
    Bakhit C; Benoit R; Bloom FE
    Regul Pept; 1983 May; 6(2):169-77. PubMed ID: 6192467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chief cells possess somatostatin receptors regulated by secretagogues acting through the calcium or cAMP pathway.
    Felley CP; O'Dorisio TM; Howe B; Coy DH; Mantey SA; Pradhan TK; Sutliff VE; Jensen RT
    Am J Physiol; 1994 May; 266(5 Pt 1):G789-98. PubMed ID: 7911277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical distribution of pro-somatostatin-related peptides in hippocampus.
    Morrison JH; Benoit R; Magistretti PJ; Ling N; Bloom FE
    Neurosci Lett; 1982 Dec; 34(2):137-42. PubMed ID: 6135179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatostatin-28- and somatostatin-14-like immunoreactivities in the rat pituitary gland.
    Mesguich P; Benoit R; Dubois PM; Morel G
    Cell Tissue Res; 1988 May; 252(2):419-27. PubMed ID: 2898294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of the distribution of prosomatostatin-derived peptides in human and monkey neocortex.
    Hayes TL; Cameron JL; Fernstrom JD; Lewis DA
    J Comp Neurol; 1991 Jan; 303(4):584-99. PubMed ID: 1672875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical and in situ hybridization analysis of the development of the rat somatostatin-containing neocortical neuronal system.
    Naus CC; Miller FD; Morrison JH; Bloom FE
    J Comp Neurol; 1988 Mar; 269(3):448-63. PubMed ID: 2897381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin(14) and -(28) but not somatostatin(1-12) hyperpolarize CA1 pyramidal neurons in vitro.
    Watson TW; Pittman QJ
    Brain Res; 1988 May; 448(1):40-5. PubMed ID: 2898967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatostatin-containing D cells exhibit immunoreactivity for rat somatostatin cryptic peptide in six mammalian species. An electron-microscopical study.
    Varndell IM; Sikri KL; Hennessy RJ; Kalina M; Goodman RH; Benoit R; Diani AR; Polak JM
    Cell Tissue Res; 1986; 246(1):197-204. PubMed ID: 2877739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of platelet-activating factor (PAF) on luteinizing hormone-releasing hormone and somatostatin release from rat median eminence in vitro correlated with the characterization of specific PAF receptor sites in rat hypothalamus.
    Junier MP; Tiberghien C; Rougeot C; Fafeur V; Dray F
    Endocrinology; 1988 Jul; 123(1):72-80. PubMed ID: 2898362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effect of somatostatin peptides on the rat anococcygeus muscle in vitro.
    Priestley T; Woodruff GN
    Br J Pharmacol; 1988 May; 94(1):87-96. PubMed ID: 2900039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.